Yamakado T, Higashiyama S, Nakano T, Takezawa H
First Department of Internal Medicine, Mie University, Tsu.
J Cardiol Suppl. 1987;16:53-63.
To assess left ventricular (LV) diastolic function in hypertrophic non-obstructive cardiomyopathy (HCM), biplane angiograms and pressures (catheter-tip manometer) were analyzed in 23 patients with HCM and 10 normal subjects (N). The effects of calcium antagonist on LV diastolic function was also evaluated by sublingual administration of 20 mg of nifedipine in 17 patients with HCM. Frame-by-frame (20 msec) analysis of angiograms was performed. LV relaxation was assessed by the time constant (T) of isovolumic LV pressure decline. 1. As compared with N, HCM showed greater increase in LV end-diastolic pressure and time constant (T). There was a significant prolongation of time from end-systole to the peak filling rate (PFR) during rapid filling period in HCM, while PFR did not differ between N and HCM. Left and upward shifts of LV diastolic pressure-volume relations were noted in HCM. Thus, abnormal LV diastolic function in HCM was characterized by impaired relaxation, delayed early diastolic filling and decreased LV compliance. 2. Clinical symptom of chest pain in HCM was associated with a decreased normalized PFR (PFR/SV and PFR/EDV). This finding suggested that an abnormal LV diastolic filling may be one of the contributing factors of chest pain in HCM. 3. Sublingual nifedipine (20 mg) did not always improve impaired relaxation and diminished LV compliance in HCM. Further study will be needed in the treatment of abnormal LV diastolic function in HCM with calcium blocking agents.
为评估肥厚型非梗阻性心肌病(HCM)患者的左心室(LV)舒张功能,对23例HCM患者和10名正常受试者(N)进行了双平面血管造影和压力(导管尖端压力计)分析。还通过对17例HCM患者舌下含服20 mg硝苯地平来评估钙拮抗剂对LV舒张功能的影响。对血管造影进行逐帧(20毫秒)分析。通过等容LV压力下降的时间常数(T)评估LV舒张。1. 与N相比,HCM患者的LV舒张末期压力和时间常数(T)升高更明显。HCM患者快速充盈期从收缩末期到峰值充盈率(PFR)的时间显著延长,而N和HCM患者的PFR无差异。HCM患者LV舒张压力-容积关系向左上方移位。因此,HCM患者LV舒张功能异常的特征为舒张受损、舒张早期充盈延迟和LV顺应性降低。2. HCM患者的胸痛临床症状与标准化PFR(PFR/SV和PFR/EDV)降低有关。这一发现提示LV舒张期充盈异常可能是HCM患者胸痛的促成因素之一。3. 舌下含服硝苯地平(20 mg)并不总能改善HCM患者舒张受损和LV顺应性降低的情况。需要进一步研究钙阻滞剂治疗HCM患者LV舒张功能异常的疗效。